Prosecution Insights
Last updated: May 29, 2026

Takara Bio Usa Inc.

6 pending office actions • 2 art units • 4 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
1
Non-Final OAs
4
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
1
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (1)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
6
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LU, FRANK WEI MIN 3 63.0% +66.3%
BERTAGNA, ANGELA MARIE 1 44.5% +46.3%
YU, TIAN NMN 1 55.1% +13.6%
CHUNDURU, SURYAPRABHA 1 53.4% +17.4%

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17276771 Methods of Preparing and Analyzing Nucleic Acid Libraries YU, TIAN NMN 252d overdue
16992595 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same LU, FRANK WEI MIN 59d overdue
17980848 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same LU, FRANK WEI MIN 17d overdue
17401662 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same BERTAGNA, ANGELA MARIE 5d
17955938 Methods of Depleting a Target Molecule from an Initial Collection of Nucleic Acids, and Compositions and Kits for Practicing the Same LU, FRANK WEI MIN 20d
16963365 Methods of Amplifying Nucleic Acids and Compositions and Kits for Practicing the Same CHUNDURU, SURYAPRABHA 30d

Top Art Units

Art UnitApps
1683 3
1681 3

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17980848 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same LU, FRANK WEI MIN 1683 §103 Non-Final OA 17d overdue Pending Nov 04, 2022
17955938 Methods of Depleting a Target Molecule from an Initial Collection of Nucleic Acids, and Compositions and Kits for Practicing the Same LU, FRANK WEI MIN 1683 §103 Final Rejection 20d Pending Sep 29, 2022
17401662 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same BERTAGNA, ANGELA MARIE 1681 §103 Final Rejection 5d Pending Aug 13, 2021
17276771 Methods of Preparing and Analyzing Nucleic Acid Libraries YU, TIAN NMN 1681 §103 Non-Final OA 252d overdue Pending Mar 16, 2021
16992595 Methods for Adding Adapters to Nucleic Acids and Compositions for Practicing the Same LU, FRANK WEI MIN 1683 §103 Final Rejection 59d overdue Pending Aug 13, 2020
16963365 Methods of Amplifying Nucleic Acids and Compositions and Kits for Practicing the Same CHUNDURU, SURYAPRABHA 1681 §103 Final Rejection 30d Pending Jul 20, 2020

Managing Takara Bio Usa Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month